By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Asuragen, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-651-0191 Fax: 512-721-4859



Start Up

Company News
Asuragen, Inc. Expands QuantideX qPCR BCR-ABL Portfolio For Monitoring Molecular Response In Chronic Myeloid Leukemia 8/3/2017 8:19:56 AM
Asuragen, Inc. Strengthens Repetitive Sequence And Short Structural Variant Intellectual Property Portfolio 4/25/2017 6:02:32 AM
Asuragen, Inc. Launches The Amplidex PCR/CE TOMM40 Kit1 Expanding Portfolio Into The Alzheimer’s And Cognitive Impairment Space 3/14/2017 6:29:03 AM
Asuragen, Inc. And Thermo Fisher Scientific (TMO) To Collaborate On Diagnostic Kits For 3500 Dx Series Genetic Analyzer 2/20/2017 7:11:19 AM
Asuragen, Inc. Launches QuantideX NGS RNA Lung Cancer Kit (RUO) 11/1/2016 3:11:04 PM
Asuragen, Inc. Develops Armored RNA Quant Zika Virus Control 8/9/2016 10:03:15 AM
Asuragen, Inc.'s QuantideX qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance For Monitoring Minimal Residual Disease In Chronic Myeloid Leukemia 7/25/2016 10:24:56 AM
Asuragen, Inc. Launches The Amplidex PCR/CE C9orf72 Kit For High-Resolution Genotyping Of GC-Rich Repeat Expansions Relevant To Amyotrophic Lateral Sclerosis And Frontotemporal Dementia 7/6/2016 9:21:05 AM
Asuragen, Inc. To Present Expansion Of Next-Generation Sequencing Portfolio At AACR Annual Meeting 4/18/2016 11:04:14 AM
Asuragen, Inc. Names Colin Hill Senior Vice President Of Commercial Operations 2/10/2016 10:42:33 AM